Chronic Myeloid Leukemia Clinical Trials in Beijing, Beijing Municipality
2 recruitingBeijing, Beijing Municipality, China
Showing 1–2 of 2 trials
Recruiting
The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP
Chronic Myeloid Leukemia
Peking University People's Hospital30 enrolled15 locationsNCT06390306
Recruiting
Phase 2
TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients
Chronic Myeloid LeukemiaAccelerated Phase CML
Shenzhen TargetRx, Inc.40 enrolled1 locationNCT06453902